Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus (Q33484138)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus (English)

1 reference

Europe PubMed Central

27 July 2017

0 references

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

4

object named as

Bray GA

1 reference

Europe PubMed Central

27 July 2017

author name string

Coniff RF

1

1 reference

Europe PubMed Central

27 July 2017

Shapiro JA

2

1 reference

Europe PubMed Central

27 July 2017

Seaton TB

3

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

1 May 1995

1 reference

Europe PubMed Central

27 July 2017

American Journal of Medicine

1 reference

Europe PubMed Central

27 July 2017

98

1 reference

Europe PubMed Central

27 July 2017

443-451

1 reference

Europe PubMed Central

27 July 2017

5

1 reference

Europe PubMed Central

27 July 2017

Hyperglycaemia and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Relationship of microvascular disease in diabetes to metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Sulfonylureas. Why, which, and how?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Principles of nutrition and dietary recommendations for individuals with diabetes mellitus: 1979. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Epidemiology of proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Diet-induced changes in serum transaminase and triglyceride levels in healthy adult men. Role of sucrose and excess calories

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Safety Profile of Acarbose, an α-Glucosidase Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980343-X

7 January 2021

Identifiers

10.1016/S0002-9343(99)80343-X

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33484138&oldid=1611998543"